NasdaqCM - Nasdaq Real Time Price USD

Aurora Cannabis Inc. (ACB)

Compare
5.49 +0.12 (+2.23%)
At close: 4:00 PM EDT
5.46 -0.03 (-0.55%)
After hours: 4:52 PM EDT
Loading Chart for ACB
DELL
  • Previous Close 5.37
  • Open 5.37
  • Bid 5.44 x 100
  • Ask 5.52 x 100
  • Day's Range 5.36 - 5.55
  • 52 Week Range 2.84 - 9.35
  • Volume 594,518
  • Avg. Volume 1,319,657
  • Market Cap (intraday) 300.188M
  • Beta (5Y Monthly) 2.71
  • PE Ratio (TTM) --
  • EPS (TTM) -0.47
  • Earnings Date Nov 7, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 31.97

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

www.auroramj.com

1,073

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ACB

View More

Performance Overview: ACB

Trailing total returns as of 10/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ACB
15.34%
S&P/TSX Composite index
14.36%

1-Year Return

ACB
1.96%
S&P/TSX Composite index
24.98%

3-Year Return

ACB
92.25%
S&P/TSX Composite index
18.95%

5-Year Return

ACB
98.90%
S&P/TSX Composite index
46.95%

Compare To: ACB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACB

View More

Valuation Measures

Annual
As of 10/2/2024
  • Market Cap

    292.98M

  • Enterprise Value

    283.09M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.42

  • Price/Book (mrq)

    0.71

  • Enterprise Value/Revenue

    1.37

  • Enterprise Value/EBITDA

    49.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.53%

  • Return on Assets (ttm)

    -1.87%

  • Return on Equity (ttm)

    -6.13%

  • Revenue (ttm)

    278.98M

  • Net Income Avi to Common (ttm)

    -30.32M

  • Diluted EPS (ttm)

    -0.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    115.49M

  • Total Debt/Equity (mrq)

    16.95%

  • Levered Free Cash Flow (ttm)

    -106.21M

Research Analysis: ACB

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 83.44M
Earnings 6.52M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

31.97
31.97 Average
5.49 Current
31.97 High
 

Company Insights: ACB

Research Reports: ACB

View More
  • Aurora Continues to Improve Profitability, but Risk for Equity Dilution Remains a Looming Threat

    Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

    Rating
    Price Target
     
  • Aurora Earnings: Shares Rally on First-Quarter Results, but We Don’t See Enough Upside for the Risk

    Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

    Rating
    Price Target
     
  • Aurora Cannabis: Slashing Fair Value Estimates as Small Size Handicaps Its Competitiveness

    Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

    Rating
    Price Target
     
  • Aurora Cannabis: Slashing Fair Value Estimates as Small Size Handicaps Its Competitiveness

    Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

    Rating
    Price Target
     

People Also Watch